Dec 05, 2019 / 01:00PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MD
Okay. Thanks, everyone, for joining us this morning. A pleasure to have Agilent with us this morning. Representing the company, we have CFO Bob McMahon. From the IR team, we have Ruben DiRado. Thank you both for coming.
For those of you who don't know me, I'm Vijay Kumar. I cover life science tools now as well as devices. It's been an interesting start to tools, where -- and I have to say Agilent has made my life a little easier here getting -- easing into 3Q. So thank you for that.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
It's our job.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MDSo Bob, maybe just -- well, I guess, this was your fiscal 4Q. Solid start -- finish to '19. Q4 came in above. One of the comments that caught my attention was CrossLabs. Because services, when I look at across tools, like everyone talks about services and